Fosun Pharmaceutical

Singapore Exchange

Lonza appoints Pierre-Alain Ruffieux as new Chief Executive Officer
ByNNR June 5, 2020June 5, 2020

BASEL, SWITZERLAND: The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective 1 November 2020. Prior to that he held roles of increasing seniority at Novartis and has over 20 years’ experience in biopharmaceuticals….

Read More Lonza appoints Pierre-Alain Ruffieux as new Chief Executive Officer
Australian Exchange

Glycotest receives $3mn second tranche of $10mn Series A financing
ByNNR November 21, 2019

NEW YORK: Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis, has received the second $3 million tranche of the $10 million Series A financing round from Shanghai Fosun Pharmaceutical Co.,…

Read More Glycotest receives $3mn second tranche of $10mn Series A financing